Zhichen Sun

2.0k total citations · 2 hit papers
32 papers, 1.5k citations indexed

About

Zhichen Sun is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Zhichen Sun has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 18 papers in Oncology and 8 papers in Biomedical Engineering. Recurrent topics in Zhichen Sun's work include Immunotherapy and Immune Responses (15 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Zhichen Sun is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Zhichen Sun collaborates with scholars based in China and United States. Zhichen Sun's co-authors include Yang‐Xin Fu, Zhida Liu, Hua Peng, Jinming Gao, Jonathan Wilhelm, Baran D. Sumer, Suxin Li, Qiang Feng, Longchao Liu and Tongyi Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Zhichen Sun

30 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity

2022 254 citations Qiang Feng, Zhida Liu et al. Nature Communications profile →
STING licensing of type I dendritic cells potentiates antitumor immunity

2024 63 citations Suxin Li, Xu Wang et al. Science Immunology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Zhichen Sun	838	648	454	207	196	32	1.5k
Nadia Guerra	1.7k 2.1×	868 1.3×	327 0.7×	151 0.7×	163 0.8×	32	2.2k
Kyohei Nakamura	986 1.2×	793 1.2×	537 1.2×	113 0.5×	99 0.5×	37	1.9k
Mingqian Feng	371 0.4×	360 0.6×	598 1.3×	109 0.5×	89 0.5×	49	1.3k
Tetsuro Sasada	1.2k 1.5×	800 1.2×	434 1.0×	132 0.6×	79 0.4×	49	1.7k
Maria J. de Miguel	562 0.7×	907 1.4×	566 1.2×	210 1.0×	108 0.6×	99	1.7k
Shaojun Xing	1.1k 1.4×	386 0.6×	461 1.0×	97 0.5×	174 0.9×	40	1.8k
Teresa Lozano	717 0.9×	481 0.7×	393 0.9×	133 0.6×	65 0.3×	43	1.2k
Stephan Fricke	456 0.5×	739 1.1×	705 1.6×	290 1.4×	101 0.5×	63	1.6k

Countries citing papers authored by Zhichen Sun

Since Specialization

Citations

This map shows the geographic impact of Zhichen Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichen Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichen Sun more than expected).

Fields of papers citing papers by Zhichen Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhichen Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichen Sun. The network helps show where Zhichen Sun may publish in the future.

Co-authorship network of co-authors of Zhichen Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhichen Sun. A scholar is included among the top collaborators of Zhichen Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhichen Sun. Zhichen Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Gang, et al.. (2025). Stimuli-responsive STING nanovaccine for systemic therapy of HPV-induced cancers. Proceedings of the National Academy of Sciences. 122(45). e2409570122–e2409570122.

Li, Suxin, Xu Wang, Shuqing Chen, et al.. (2024). STING licensing of type I dendritic cells potentiates antitumor immunity. Science Immunology. 9(92). eadj3945–eadj3945. 63 indexed citations breakdown →

Wang, Xinyue, Fanyan Meng, Xiang Li, et al.. (2023). Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors. Advanced Science. 10(12). e2205044–e2205044. 14 indexed citations

Wang, Xinyue, Xiang Li, Lin Li, et al.. (2023). Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (Adv. Sci. 12/2023). Advanced Science. 10(12). 1 indexed citations

Bei, Yuncheng, Yanhong Chu, Zhichen Sun, et al.. (2023). Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressing universal T cell receptor‐engineered T (HAUL TCR‐T) cell therapy in solid tumor. Bioengineering & Translational Medicine. 8(6). e10585–e10585. 6 indexed citations

Gao, Yu, Qi Luo, Zhichen Sun, et al.. (2023). Implication of ^99mTc-sum IL-2 SPECT/CT in immunotherapy by imaging of tumor-infiltrating T cells. Journal for ImmunoTherapy of Cancer. 11(3). e005925–e005925. 4 indexed citations

Feng, Qiang, Zhida Liu, Xuexin Yu, et al.. (2022). Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nature Communications. 13(1). 4981–4981. 254 indexed citations breakdown →

Bae, Joonbeom, Longchao Liu, Casey Moore, et al.. (2022). IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer. Nature Cell Biology. 24(12). 1754–1765. 51 indexed citations

Sun, Zhichen, Rutian Li, Yun Shen, et al.. (2022). In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors. Journal of Hematology & Oncology. 15(1). 29–29. 20 indexed citations

10.

Hsu, Eric J., Xuezhi Cao, Joonbeom Bae, et al.. (2021). A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy. Nature Communications. 12(1). 2768–2768. 85 indexed citations

11.

Liu, Longchao, Jiahui Chen, Joonbeom Bae, et al.. (2021). Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells. Nature Biomedical Engineering. 5(11). 1261–1273. 57 indexed citations

12.

Wang, Xu, Jonathan Wilhelm, Wei Li, et al.. (2020). Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window. Nature Communications. 11(1). 5828–5828. 79 indexed citations

13.

Liu, Fangcen, Lifeng Wang, Chen Xie, et al.. (2020). <p>Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells</p>. International Journal of Nanomedicine. Volume 15. 1283–1295. 27 indexed citations

14.

Sun, Zhichen, Zhenhua Ren, Kaiting Yang, et al.. (2019). A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control. Nature Communications. 10(1). 3874–3874. 147 indexed citations

15.

Yang, Kaiting, Yong Liang, Zhichen Sun, et al.. (2018). T cell-derived lymphotoxin limits Th1 response during HSV-1 infection. Scientific Reports. 8(1). 17727–17727. 5 indexed citations

16.

Liang, Yong, Haidong Tang, Jingya Guo, et al.. (2018). Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance. Nature Communications. 9(1). 4586–4586. 69 indexed citations

17.

Sun, Zhichen, Yang‐Xin Fu, & Hua Peng. (2018). Targeting tumor cells with antibodies enhances anti-tumor immunity. Biophysics Reports. 4(5). 243–253. 18 indexed citations

18.

Liao, Jing, Yan Luan, Zhenhua Ren, et al.. (2017). Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression. Cancer Immunology Research. 5(7). 560–570. 13 indexed citations

19.

Yu, Yi, Pin Wan, Yanhua Cao, et al.. (2017). Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action. Scientific Reports. 7(1). 1729–1729. 26 indexed citations

20.

Ren, Zhenhua, Jingya Guo, Jing Liao, et al.. (2016). CTLA-4 Limits Anti-CD20–Mediated Tumor Regression. Clinical Cancer Research. 23(1). 193–203. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact